Skip to content
healthcare.dev

Irinotecan Hydrochloride

NDC 60505-6128, Irinotecan Hydrochloride, injection, solution, from Apotex Corp..

Product NDC
60505-6128
Status
Listed
Labeler
Apotex Corp.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203380
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6128 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
60505-6128-0605056128001 VIAL, SINGLE-USE in 1 CARTON (60505-6128-0) / 2 mL in 1 VIAL, SINGLE-USE
60505-6128-1605056128011 VIAL, SINGLE-USE in 1 CARTON (60505-6128-1) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/85ed6019-f462-4abe-a89e-ad991623c86d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=60505-6128

Use it

Look up 60505-6128 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6128 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6128. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.